Coins Set to Soar with a Pro-Crypto White House

Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over $3 Million worth of crypto – and he's not the only one at the top interested in digital assets…

Click here to reserve your free seat at the Crypto Community Summit

John Kenneweg Biography and Net Worth

VP of 908 Devices

John W. Kenneweg is VP-Government Business & GM-Field Forensics at 908 Devices, Inc.

In his past career Mr. Kenneweg was Director-Federal Government Programs at Thermo Fisher Scientific, Inc. and Principal at Ahura Scientific, Inc. (a subsidiary of Thermo Fisher Scientific, Inc.), Manager-Business Development at Draeger Safety, Inc. and Principal at United States Marine Corps.

Mr. Kenneweg received an undergraduate degree from West Virginia University.

What is John Kenneweg's net worth?: The estimated net worth of John Kenneweg is at least $25,600.00 as of July 16th, 2021. Mr. Kenneweg owns 10,000 shares of 908 Devices stock worth more than $25,600 as of November 24th. This net worth estimate does not reflect any other assets that Mr. Kenneweg may own. Learn More about John Kenneweg's net worth.
How do I contact John Kenneweg?: The corporate mailing address for Mr. Kenneweg and other 908 Devices executives is , , . 908 Devices can also be reached via phone at 857-254-1500 and via email at [email protected]. Learn More on John Kenneweg's contact information.
Has John Kenneweg been buying or selling shares of 908 Devices?: John Kenneweg has not been actively trading shares of 908 Devices during the last ninety days. Most recently, John Kenneweg sold 19,881 shares of the business's stock in a transaction on Friday, March 18th. The shares were sold at an average price of $20.06, for a transaction totalling $398,812.86. Learn More on John Kenneweg's trading history.
Who are 908 Devices' active insiders?: 908 Devices' insider roster includes Nicolas Barthelemy (VP), Trent Basarsky (VP), Christopher Brown (CTO), Joseph Griffith, IV (CFO), John Kenneweg (VP), and Kevin Knopp (CEO). Learn More on 908 Devices' active insiders.
Are insiders buying or selling shares of 908 Devices?: In the last year, 908 Devices insiders bought shares 3 times. They purchased a total of 30,000 shares worth more than $178,500.00. In the last year, insiders at the sold shares 6 times. They sold a total of 40,346 shares worth more than $324,982.08. The most recent insider tranaction occured on May, 13th when CEO Kevin J Knopp bought 10,000 shares worth more than $64,200.00. Insiders at 908 Devices own 27.7% of the company. Learn More about insider trades at 908 Devices.
Information on this page was last updated on 5/13/2024.

John Kenneweg Insider Trading History at 908 Devices

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/18/2022	Sell	19,881	$20.06	$398,812.86
3/11/2022	Sell	119	$20.00	$2,380.00
1/11/2022	Sell	9,300	$20.15	$187,395.00
11/16/2021	Sell	10,000	$30.32	$303,200.00
10/18/2021	Sell	10,000	$32.22	$322,200.00
7/16/2021	Sell	10,000	$32.27	$322,700.00	10,000
6/16/2021	Sell	10,000	$39.27	$392,700.00	10,000

John Kenneweg Buying and Selling Activity at 908 Devices

908 Devices Company Overview

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $2.56

$2.55

$2.74

50 Day Range

MA: $3.32

$2.34

$3.91

2 Week Range

Now: $2.56

$2.19

$12.51

Volume

210,506 shs

Average Volume

367,700 shs

Market Capitalization

$89.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98